Sanofi Halts International Drug Trial For COVID-19 After Inconclusive Results In Phase III

French pharma giant Sanofi has now halted its international drug trial for Kevzara- a Sarilumab monoclonal antibody after it showed inconclusive results in moderately and severely affected COVID-19 patients in trials outside the US. The trial was in Phase III.  

In early July, the pharmaceutical had stopped trials for the drug in US but still decided to continue its international trials in Argentina, Brazil, Canada, Chile, France, Germany, Israel, Italy, Japan, Russia and Spain.